1 through 12 years:
15 kg or less: 30 mg orally once a day
through 23 kg: 45 mg orally once a day
through 40 kg: 60 mg orally once a day
kg or greater: 75 mg orally once a day
13 years or older: 75 mg orally once a day
Duration of therapy:
-After close contact with an infected individual: 10 days
-During a community outbreak of influenza: May be continued for up to 6 weeks
-Therapy should begin within 48 hours of exposure.
-The FDA has not approved dosing for patients less than 1 year of age.
(Not approved by FDA)
AAP recommendations for full-term infants:
Less than 3 months: Not recommended unless situation judged critical.
3 months to less than 1 year: 3 mg/kg orally once a day